Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment

Regeneron Pharmaceuticals Inc is working with the U.S. Department of Health and Human Services (HHS) to develop a treatment for the coronavirus outbreak that has killed more than 400 people in China, the HHS said on Tuesday.